AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionAchmea Investment Management B.V.
Latest Disclosed Ownership365,642 shares
Latest Disclosed Value $ 79,523
Achmea Investment Management B.V. reports 4.34% increase in ownership of ABBV / AbbVie Inc.

On May 13, 2026 - Achmea Investment Management B.V. filed a 13F-HR form disclosing ownership of 365,642 shares of AbbVie Inc. (MX:ABBV) valued at $79,523 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 350,442 shares of AbbVie Inc.. This represents a change in shares of 4.34% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AbbVie Equity 00287Y109 365,642 15,200 4.34 80 -1.25 2.0991
2026-02-18 2025-12-31 13F ABBVIE Equity 00287Y109 350,442 -13,897 -3.81 80 -4.76 2.0440
2025-11-21 2025-09-30 13F AbbVie Equity 00287Y109 364,339 5,767 1.61 84 27.27 1.0485
2025-08-06 2025-06-30 13F AbbVie Equity 00287Y109 358,572 4,327 1.22 67 -10.81 0.8589
2025-04-24 2025-03-31 13F AbbVie Equity 00287Y109 354,245 23,585 7.13 74 27.59 1.0810
2025-02-10 2024-12-31 13F AbbVie Equity 00287Y109 330,660 -5,460 -1.62 59 -12.12 0.9665
2024-11-12 2024-09-30 13F AbbVie Equity 00287Y109 336,120 9,495 2.91 66 17.86 1.0946
2024-08-08 2024-06-30 13F AbbVie Equity 00287Y109 326,625 18,304 5.94 56 0.00 1.0026
2024-05-08 2024-03-31 13F AbbVie Equity 00287Y109 308,321 38,470 14.26 56 36.59 1.0697
2024-02-12 2023-12-31 13F AbbVie Equity 00287Y109 269,851 -16,009 -5.60 42 -2.38 0.8630
2023-11-06 2023-09-30 13F AbbVie Equity 00287Y109 285,860 -2,128 -0.74 43 10.53 0.9298
2023-07-24 2023-06-30 13F AbbVie Equity 00287Y109 287,988 33,590 13.20 39 -5.00 0.8190
2023-05-04 2023-03-31 13F AbbVie Equity 00287Y109 254,398 21,847 9.39 41 14.29 1.1758
2023-02-09 2022-12-31 13F AbbVie Equity 00287Y109 232,551 5,175 2.28 35 -99.89 1.1807
2022-10-27 2022-09-30 13F AbbVie Equity 00287Y109 227,376 227,376 30,516 1.0796
2022-08-10 2022-06-30 13F AbbVie Equity 00287Y109 0 -193,214 -100.00 0 -100.00
2022-05-16 2022-03-31 13F AbbVie Equity 00287Y109 193,214 25,860 15.45 31,322 38.23 0.8161
2022-02-10 2021-12-31 13F AbbVie Equity 00287Y109 167,354 37,093 28.48 22,660 61.27 1.0773
2021-11-12 2021-09-30 13F AbbVie Equity 00287Y109 130,261 -23,575 -15.32 14,051 -18.91 0.4267
2021-08-06 2021-06-30 13F AbbVie Equity 00287Y109 153,836 -18,384 -10.67 17,328 -7.03 0.5906
2021-05-11 2021-03-31 13F ABBVIE INC COM Equity 00287Y109 172,220 -17,222 -9.09 18,638 -8.18 0.6501
2021-02-22 2020-12-31 13F ABBVIE INC COM Equity 00287Y109 189,442 5,859 3.19 20,299 26.23 0.7335
2020-11-02 2020-09-30 13F ABBVIE INC COM Equity 00287Y109 183,583 -344,770 -65.25 16,081 -69.00 0.6709
2020-08-12 2020-06-30 13F AbbVie Equity 00287Y109 528,353 528,353 51,874 1.7551
2020-05-13 2020-03-31 13F AbbVie ABBV US 00287Y109 0 -151,369 -100.00 0 -100.00
2020-02-10 2019-12-31 13F AbbVie ABBV US 00287Y109 151,369 -30,924 -16.96 13,402 -2.91 0.5167
2019-11-14 2019-09-30 13F AbbVie ABBV US 00287Y109 182,293 15,745 9.45 13,803 13.94 0.5449
2019-08-06 2019-06-30 13F AbbVie ABBV US 00287Y109 166,548 2,413 1.47 12,114 -8.41 0.4628
2019-05-15 2019-03-31 13F AbbVie ABBV US 00287Y109 164,135 -2,811 -1.68 13,227 -14.06 0.5509
2019-02-14 2018-12-31 13F AbbVie ABBV US 00287Y109 166,946 -90,788 -35.23 15,391 -36.85 0.7112
2018-11-06 2018-09-30 13F AbbVie ABBV US 00287Y109 257,734 -28,351 -9.91 24,372 -8.04 0.9227
2018-07-27 2018-06-30 13F AbbVie ABBV US 00287Y109 286,085 44,075 18.21 26,502 15.71 0.9265
2018-05-15 2018-03-31 13F AbbVie ABBV US 00287Y109 242,010 -15,023 -5.84 22,904 -7.85 0.7732
2018-02-12 2017-12-31 13F AbbVie ABBV US 00287Y109 257,033 140,860 121.25 24,854 140.83 0.8384
2017-11-09 2017-09-30 13F AbbVie ABBV US 00287Y109 116,173 1,620 1.41 10,320 24.28 0.5851
2017-08-29 2017-06-30 13F/A-1 AbbVie ABBV US 00287Y109 114,553 -6,156 -5.10 8,304 5.58 0.4990
2017-05-23 2017-03-31 13F/A-1 AbbVie ABBV US 00287Y109 120,709 120,709 7,865 0.3688
2017-05-15 2017-03-31 13F AbbVie ABBV US 00287Y109 120,709 7,865
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.